Finally, by correlating the status of AK4 mRNA expression with drug sensitivity data in lung adenocarcinoma cell lines, we proposed lung cancer cells that have high levels of AK4 might be sensitive to EGFR target therapy. The gene discussed is EGFR; the disease is lung carcinoma.